Midi Health vs Noom
Midi Health and Noom sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Midi Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Midi Health →
If you are choosing between Midi Health and Noom, price alone will not settle it. Noom leads our six-part score, 6.7 to 4.6.
Midi Health vs Noom price
Noom publishes $199 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Noom lists semaglutide and tirzepatide; Midi Health does not name its drug.
On format, Midi Health posts no priced format, while Noom prices brand-name pens and compounded injections.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Midi Health lists 50 states, and Noom does not publish where it ships.
Pricing
Midi Health
Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
Noom
What each price covers
Noom's price also covers the clinician visit and coaching, which Midi Health does not claim.
Midi Health does not say what its price includes.
Noom is silent on the medication itself, shipping and lab work.
Midi Health
Inclusions not disclosed.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Noom scores 6.7 and Midi Health 4.6 out of 10.
Midi Health is stronger on accessibility (10.0 vs 5.0) and support (5.0 vs 4.0).
Noom is stronger on value (4.4 vs 3.0), effectiveness (10.0 vs 5.0), user experience (8.0 vs 2.5) and trust & safety (6.5 vs 5.0).
Midi Health
4.6/10
Noom
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Midi Health nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | Midi Health | Noom |
|---|---|---|
| Starting Price | Not published | $199/mo |
| Features | ✓5 features | 2 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Midi Health
Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.
Read our full Midi Health review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
Midi Health
What we like
- Serves all 50 states
- We found no FDA warning letters issued to Midi Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 4.6, above all for coaching bundled into the price rather than sold separately. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Midi Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Midi Health vs Noom: FAQ
Close alternatives to Midi Health and Noom
- Midi Health vs Embody
- Midi Health vs TrimRx
- Midi Health vs Henry Meds
- Midi Health vs Hims
- Noom vs Hims
- Noom vs Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.